An investigation into an unusual glycan branching enzyme from Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb), the pathogen that causes tuberculosis (TB), is showing increasing resistance to current drug therapies. It is therefore essential that novel drug targets and drug therapies are discovered. Methylglucose lipopolysaccharides (MGLPS) are glycoconjugates produced by Myc...
Main Author: | Gusthart, Jessica Sophie |
---|---|
Other Authors: | Lee, Seung |
Published: |
University of Southampton
2018
|
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.759290 |
Similar Items
-
Automated glycan assembly of arabinomannan oligosaccharides from Mycobacterium tuberculosis
by: Alonso Pardo-Vargas, et al.
Published: (2019-12-01) -
Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer
by: Yasuhiko Kizuka, et al.
Published: (2016-04-01) -
A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis
by: Rohitesh Gupta, et al.
Published: (2020-02-01) -
Hemophagocytic lymphohistiocytosis: An unusual complication in disseminated Mycobacterium tuberculosis
by: Somanath Padhi, et al.
Published: (2015-01-01) -
An unusual association between Mycobacterium tuberculosis and Aspergillus fumigatus
by: R. Agarwal, et al.
Published: (2016-01-01)